These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1414502)

  • 1. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
    Tang LY; Jee WS; Ke HZ; Kimmel DB
    J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass.
    Jee WS; Tang L; Ke HZ; Setterberg RB; Kimmel DB
    Bone; 1993; 14(3):493-8. PubMed ID: 8363898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
    Jee WS; Lin BY; Ma YF; Ke HZ
    J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen does not restore bone lost after ovariectomy in the rat.
    Abe T; Chow JW; Lean JM; Chambers TJ
    J Bone Miner Res; 1993 Jul; 8(7):831-8. PubMed ID: 8352066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
    Ma Y; Chen YY; Jee WS; Ke HZ; Ijiri K
    Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
    Bone; 1994; 15(5):489-96. PubMed ID: 7980959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Calcif Tissue Int; 2006 Nov; 79(5):318-25. PubMed ID: 17048065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of PGE2 is catabolic with a negative bone balance on both cancellous and cortical bone in rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Ma YF; Jee W SS
    J Musculoskelet Neuronal Interact; 2007; 7(4):372-81. PubMed ID: 18094515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
    Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ
    Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.
    Desimone DP; Greene VS; Hannon KS; Turner RT; Bell NH
    J Bone Miner Res; 1993 May; 8(5):625-34. PubMed ID: 8511990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.